Prospective StudentsCurrent StudentsDepartmentsDegree ProgramsFaculty & StaffDevelopmentCalendarsMore News

Professor Yang AACP's 2003 Paul Dawson Biotechnology Award Winner

Albert B. Prescott Professor of Pharmaceutical Sciences, Victor C. Yang, is the 2003 recipient of the American Colleges of Pharmacy (AACP) Paul Dawson Biotechnology Award. The award is presented annually to one individual for exemplary contributions to teaching and scholarship in biotechnology and its related science. Yang is the 11th academic scientist so honored.

His achievement will be recognized during the AACP annual meeting awards banquet on July 22 in Minneapolis, Minn. The award, sponsored by Amgen Inc., consists of a double helix glass sculpture, a $10,000 cash prize, and an invitation to present a lecture at a special July 21 session.

"Victor has distinguished himself in several areas: as an outstanding researcher in the areas of biotechnology-mediated diagnostics and drug delivery, for his dedication to teaching, and for his service to our College and University," explains David E. Smith, professor and chairman of the Pharmaceutical Sciences Department. Smith was one of several colleagues who nominated Yang for the Dawson Biotechnology Award."

Of particular note, Smith adds, is Yang's pioneering work on electrochemical sensors for polyionic macromolecules, such as heparin and protamine; his sensor-directed, protamine bioreactor-based, biofeedback system for clinical heparin removal; and his seminal "ATTEMPTS" approach for delivering enzyme drugs, such as t-PA, without the associated toxic effects.

Yang, who joined the College in 1986, received his PhD in biochemistry and biophysics from Brown University in 1983, followed by a post-doctoral research study in chemical engineering at MIT. He has published more than 130 peer-reviewed research articles, has 15 patents, and has given nearly 150 presentations, many of them to international science groups, "a clear indication that his expertise in pharmaceutical biotechnology is of great interest to scientists worldwide," Smith adds.

Since 1987, Yang has received more than $9 million in grant support, mainly from the National Institutes of Health (NIH), but also from industries, such as Medtronic. His research has recently moved into new areas, namely brain drug delivery systems for the treatment of Parkinson's and Alzheimer's diseases; protein and gene delivery for the treatment of various types of cancers; and the design of bioreactors for the treatment of autoimmune diseases, such as immune thrombocytopenia purpura and multiple sclerosis.

Yang teaches a biopharmaceutics and biotechnology course to PharmD students, and a current topics in biotechnology course to PhD candidates. During his career at U-M, he has mentored 28 PhD students, two MS students, 21 postdoctoral fellows. Forty percent of PhD students trained in Yang's laboratory now have faculty positions at major universities.

Outside the College, Yang serves on the Board of Scientific Advisors of the Controlled Release Society, and is on editorial boards of several scientific journals. He was a University Guest Professor at Tianjin University, China, in 2001, and in 2002 was recipient of the Short-Term Invitation Fellowship for Research, jointly sponsored by the U.S. National Science Foundation (NSF) and the Japan Society for the Promotion of Science (JSPS). He is also a member of the NIH Surgery and Bioengineering Study Section.

AACP, the national accrediting organization of all U.S. colleges and schools of pharmacy.

Sitemap | Feedback | Faculty&Staff Intranet | University of Michigan
428 Church Street / Ann Arbor, MI 48109-1065 / (734) 764-7312
©2003 / page last modified: Thursday, 01-May-2003 14:04:54 EDT